Search

News

U.S. starts vaccinating children as young as 6 months
... the shots will improve in the coming days, according to White House COVID 19 response coordinator Dr. Ashish Jha . The U.S. regulators approved Moderna Inc's MRNA.O two-dose vaccine for children aged six months to five years and the Pfizer PFE.N BioNTech three-shot regimen for children aged six months to four years late last week. It is not known how many parents will vaccine their youngest children. A survey by the Kaiser Family Foundation shows that just one-in-five parents with children under ...
Updated: 06/21/2022
Hong Kong experts extend dosing interval between BioNTech vaccine to 8 weeks
HONG KONG experts who advise the Hong Kong government on COVID 19 vaccination have recommended extending the interval between the first and the second doses of the BioNTech vaccine to eight weeks to reduce the risk of myocarditis. HONG KONG experts who advise the Hong Kong government on COVID 19 vaccination have recommended extending the interval between the first and the second doses of the BioNTech vaccine to ...
Updated: 06/18/2022
FDA advisory panel votes 21-0 to approve Moderna’s COVID-19 vaccines for children under 5 years old
... the epidemic. An FDA advisory committee voted on Wednesday 21 -- 0 that the benefits of Moderna 's MRNA, two-dose vaccine for children between the ages of 6 months old and 5 years old outweigh the risks. The committee also voted 21 -- 0 in favor of BioNTech BNTX and Pfizer 's PFE , three-dose COVID-19 vaccine for children between the ages of 6 months old and 4 years old. The advisory committee is not required to follow the advice of the FDA . The next step in the regulatory process is getting ...
Updated: 06/15/2022
Moderna moves one step closer to approval of COVID vaccine for 2 more age groups
... Prevention's advisory committee will meet later this week to make a formal decision on the issue, and the FDA has yet to make a formal decision. Once both agencies make a decision, the doses will be released for use. Moderna has lag behind rival Pfizer PFE BioNTech BNTX in filing for the younger age groups, after receiving emergency use authorization in December 2020 and full approval earlier this year for adults. Both vaccines use mRNA technology. The advisory committee of the FDA voted 22 -- 0 to recommend ...
Updated: 06/15/2022
Sanofi says its next-gen COVID booster shows 40 fold increase in antibody protection
... booster candidate is based on the beta variant and uses an adjuvant developed by GlaxoSmithKline GSK . The company said that its experimental next-generation booster generated a better immune response when compared to the traditional booster developed by BioNTech SE BNTX , and Pfizer Inc. PFE , and Sanofi 's first-generation booster. The data was published in May as a preprint. Sanofi plans to submit data for its next-generation booster to regulatory authorities within a few weeks. The U.S. listed ...
Updated: 06/13/2022
India says vaccine waiver fundamental to saving lives
... Goyal was indirectly referring to the fact that only 14 per cent of people in low-income countries have been vaccinated with one dose in the third year of the disease, while in November last year, the People's Vaccine Alliance reported that Pfizer, BioNTech and Moderna , the companies behind two of the most successful COVID 19 vaccines, were making $65,000 every minute. Pharma giants like Pfizer and BioNTech delivered less than 1 per cent of their vaccine supplies to low-income countries, while ...
Updated: 06/13/2022
Moderna Covid vaccine appears safe in children, FDA says
... of age. The FDA staff said that the vaccine generally had a similar side effect profile in children as seen in adults, although younger children had fevers more often. Both of the messenger RNA -based Covid 19 vaccines made by Moderna and Pfizer BioNTech have been linked to rare instances of a type of heart inflammation called myocarditis, particularly in young men. Some countries in Europe have limited the use of Moderna s shots for younger age groups after some studies showed that it was linked ...
Updated: 06/12/2022
Biden administration gearing up to vaccinate children under 5
... federal regulators. The Biden administration is gearing up to roll out vaccines for children under age 5 in conjunction with educational and outreach efforts, if the shots are approved by federal regulators. If Moderna MRNA , Pfizer PFE , and partner BioNTech BNTX are approved by the Food and Drug Administration , vaccines for children under 5 years old could begin as soon as June 21. Ten million initial doses will be available, senior administration officials said. The vaccinations would also be ...
Updated: 06/09/2022
Sort by relevance | Sorted by date